You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer models
- 2. Sped-up evolution may help bacteria take hold in gut microbiome, UCLA-led research team finds
- 3. The clinical validity of radiomics-based prediction of molecular subtypes in breast cancer from digital mammary tomosynthesis
- 4. IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances
- 5. General Oncology to Present Preliminary Phase 1 Results from SHARON Trial in Patients with BRCA/PALB2-mutated Pancreatic and Breast Cancer at ESMO 2025
- 6. Pink truck hits the road to help breast cancer patients
- 7. European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd study
- 8. Cancer outcomes of pregnancy after diagnosis of breast cancer in premenopausal women: an updated systematic review and meta-analysis
- 9. The role of immune- and lipid metabolism-related genes in macrophage polarization and prognosis of glioblastoma
- 10. Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting
Last updated at 17:49 GMT
Hot News Makers
Health/Pharma Companies
-
367487.84
-
18238.86
-
13457.93
-
11962.50
-
11001.67
-
8387.77
-
8335.12
-
7271.38
-
7092.60
-
6240.39
Drugs, Treatments, Trials
-
28554.51
-
27935.98
-
7574.47
-
7472.16
-
6349.77
-
6312.06
-
4407.46
-
3905.42
-
2913.01
-
2782.39
Last updated at 17:10 GMT
